Sophiris Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sophiris Bio generated cash of -$13,457,000, which is less than the previous year. Cash used in financing activities reached the amount of $102,000 last year. Net change in cash is therefore -$5,089,000.
Cash Flow
| 2010 | -3.16M | -6.57K | 13.71M |
|---|---|---|---|
| 2011 | -11.31M | -198.73K | 22.61M |
| 2012 | -17.80M | 82.97K | 3.74M |
| 2013 | -13.20M | -33.32M | 51.72M |
| 2014 | -26.23M | 14.69M | 839K |
| 2015 | -14.35M | 16.06M | 50K |
| 2016 | -10.32M | -13.72M | 30.97M |
| 2017 | -9.96M | 6.32M | 6.93M |
| 2018 | -13.45M | 8.26M | 102K |
SPHS Cash Flow Statement (2010 – 2018)
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 16.08M | 12.8M | 5.88M | 4.12M | 14.83M | 9.72M | 23.41M | 12.38M | 1.76M |
Operating activities | |||||||||
Net income | -6.77M | -8.62M | -11.16M | -14.19M | -30.71M | -11.14M | -21.16M | -14.21M | -4.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 2K | 4K | 12K | 20K | 47K | 84K | 231.03K | 245.93K | 218.76K |
Stock-based compensation expense | 860K | 1.71M | 425K | 776K | 2.09M | 1.17M | 675.95K | 915.43K | 471.38K |
| Deferred income tax benefit | 860K | 1.71M | 425K | 776K | 2.09M | 1.17M | 675.95K | 915.43K | 471.38K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 963K | 374K | -446K | -1.72M | 1.17M | -305K | 0 | 0 | 556.09K |
Cash generated by operating activities | -13.45M | -9.96M | -10.32M | -14.35M | -26.23M | -13.20M | -17.80M | -11.31M | -3.16M |
Investing activities | |||||||||
Purchases Of Investments | -3.61M | -15.83M | -16.47M | -10.10M | -28.50M | -33.32M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4K | -3K | 0 | 0 | -9K | -3K | -25.67K | -265.46K | -6.57K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 8.26M | 6.32M | -13.72M | 16.06M | 14.69M | -33.32M | 82.97K | -198.73K | -6.57K |
Financing activities | |||||||||
Common Stock Issued | 102K | 0 | 33.53M | 785K | 1.89M | 57.25M | 0 | 8.13M | 13.48M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -5.14M | 0 | -3.36M | -5.52M | -3.18M | 0 | -3.66K |
Cash used in financing activities | 102K | 6.93M | 30.97M | 50K | 839K | 51.72M | 3.74M | 22.61M | 13.71M |
Net Change In Cash | -5.08M | 3.28M | 6.91M | 1.75M | -10.71M | 5.11M | -13.68M | 11.02M | 10.54M |
Cash at end of period | 10.99M | 16.08M | 12.8M | 5.88M | 4.12M | 14.83M | 9.72M | 23.41M | 12.31M |
| Data source | Data source | Data source | Data source | Data source | Data source |